Tuberculosis is an infectious disease that kills lakhs of Indians every year. Early detection of the disease is key to administering treatment; however, this has been hampered by the fact that current diagnostic techniques are often costly and time-consuming. Now, researchers from the Indian Institute of Science, Bengaluru, have come up with an inexpensive paper-based diagnostic device for tuberculosis detection.
As the problem of antibiotic resistance mounts worldwide, there is a pressing need for identifying and testing novel drug targets. Recently, a team of researchers from the Indian Institute of Science Education and Research (IISER), Pune, and the Central Drug Research Institute (CSIR-CDRI), Lucknow, has identified a protein pathway in an antibiotic-resistant bacterial strain which can be targeted using a small molecule to effectively kill the bacteria.
A recurring challenge for combination cancer therapy has been delivering drugs with widely differing properties to the tumour site. Now, researchers at the Regional Centre for Biotechnology, Faridabad, and Amity University, Haryana, have come up with a novel strategy for combining three different drugs into a single package that can induce tumour shrinkage when injected.
Uncontrolled blood loss following an accident or injury can pose severe risks to the health and life of the patient. Now, a team of Indian researchers from the Institute of Nano Science and Technology have developed a novel environment-friendly microparticle which can stop bleeding quickly if applied to the injury site.
In a country where more than 80% of medical devices are imported, IIT Bombay researchers have developed India’s first biodegradable bone screw. The screw is made of a polymer-based biomaterial which contains Magnesium Oxide nanoparticles and silk fibres, and its mechanical strength can be tuned to match the target tissue.
BioAsia, one of the largest annual biotechnology conferences in Asia, was held at Hyderabad from 25th -27th February 2019. With this year’s theme being “Life Sciences 4.0 – Disrupt the Disruption”, BioAsia addressed roadmaps, policies and economic changes required for the progress of biotechnology, particularly with regards to applications like digital healthcare, personalized medicine and new-age therapeutics.
At BioAsia 2018, scientists, entrepreneurs and politicians come together to discuss the future of biotechnology in India.